Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
CAMP

Updated 10/6/2026, 8:56 AM ET.

CAMP

Camp4 Therapeutics Corp

Buy$39,600

Gold Kelly

Chief Financial Officer

10,000 shat $3.96Filed Sep 2, 7:50 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Sale$1,616,000

Schwab Andrew J.

Director

400,000 shat $4.04Filed Aug 31, 5:05 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Sale$45

Schwab Andrew J.

Director

10 shat $4.50Filed Aug 26, 4:57 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Sale$879,719

Schwab Andrew J.

Director

191,865 shat $4.59Filed Aug 21, 4:59 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Sale$8,273

Tardiff Daniel

Chief Scientific Officer

1,738 shat $4.76Filed Aug 19, 8:46 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Buy$27,024

Young Richard A

Director

16,378 shat $1.65Filed Aug 5, 5:09 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Buy$10,809

Maricich Yuri

Chief Medical Officer

6,551 shat $1.65Filed Aug 5, 5:08 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Buy$10,809

Gold Kelly

Chief Financial Officer

6,551 shat $1.65Filed Aug 5, 5:08 PM ETFiling
CAMP

Camp4 Therapeutics Corp

Buy$10,809

Mandel-Brehm Josh

Chief Executive Officer, Director

6,551 shat $1.65Filed Aug 5, 5:07 PM ETFiling

Read from public SEC filings. Not financial advice.